HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 196 filers reported holding HERON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $232,000 | +30.3% | 15,805 | +4.4% | 1.09% | -2.7% |
| Q1 2020 | $178,000 | -50.4% | 15,135 | -1.0% | 1.12% | -26.0% |
| Q4 2019 | $359,000 | -14.3% | 15,295 | -32.5% | 1.52% | -14.0% |
| Q3 2019 | $419,000 | -2.6% | 22,665 | -6.0% | 1.76% | +12.3% |
| Q2 2019 | $430,000 | -10.0% | 24,112 | +23.3% | 1.57% | -17.4% |
| Q1 2019 | $478,000 | +38.6% | 19,553 | +47.0% | 1.90% | -14.7% |
| Q4 2018 | $345,000 | +1.8% | 13,299 | +24.3% | 2.23% | +27.4% |
| Q3 2018 | $339,000 | -58.9% | 10,696 | -49.6% | 1.75% | -52.3% |
| Q2 2018 | $825,000 | -10.5% | 21,233 | -36.4% | 3.66% | -5.6% |
| Q1 2018 | $922,000 | +50.4% | 33,389 | -1.4% | 3.88% | +39.8% |
| Q4 2017 | $613,000 | +14.2% | 33,875 | +1.8% | 2.78% | +9.8% |
| Q3 2017 | $537,000 | +5.5% | 33,274 | -9.4% | 2.53% | +5.2% |
| Q2 2017 | $509,000 | – | 36,744 | – | 2.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |